Aakash Shah

Dr. Aakash Shah

Division of Cardiac Surgery, Department of Surgery, University of Maryland School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2022 in New England Journal of Medicine
Verified
Journal Article
Closed access
BGBartley P Griffith
Bartley P Griffith
CGCorbin E. Goerlich
Corbin E. Goerlich
ASAvneesh K. Singh
Avneesh K. Singh
MRMartine Rothblatt
Martine Rothblatt
CLChristine L. Lau
Christine L. Lau
MMMuhammad M. Mohiuddin
Muhammad M. Mohiuddin
A 57-year-old man with nonischemic cardiomyopathy who was dependent on venoarterial extracorporeal membrane oxygenation (ECMO) and was not a candidate for standard therapeutics, including a traditional allograft, received a heart from a genetically modified pig source animal that had 10 individual gene edits. Immunosuppression was based on CD40 blockade. The patient was weaned from ECMO, and the xenograft functioned normally without apparent rejection. Sudden diastolic thickening and failure of the xenograft occurred on day 49 after transplantation, and life support was withdrawn on day 60. On autopsy, the xenograft was found to be edematous, having nearly doubled in weight. Histologic examination revealed scattered myocyte necrosis, interstitial edema, and red-cell extravasation, without evidence of microvascular thrombosis — findings that were not consistent with typical rejection. Studies are under way to identify the mechanisms responsible for these changes. (Funded by the University of Maryland Medical Center and School of Medicine.)

21 July 2019 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Closed access
CPChetan Pasrija
Chetan Pasrija
MSMariem A Sawan
Mariem A Sawan
ESErik Sorensen
Erik Sorensen
HVHannah Voorhees
Hannah Voorhees
ASAakash Shah
Aakash Shah
ZKZachary N Kon
Zachary N Kon
OBJECTIVES: Right ventricular (RV) failure after left ventricular assist device (LVAD) implantation continues to be a morbid complication. In this study, we hypothesized that a less invasive approach to implantation would preserve RV function relative to a conventional sternotomy (CS) approach. METHODS: All patients (2013–2017) who underwent LVAD implantation were reviewed. Patients were stratified by surgical approach: less invasive left thoracotomy with hemi-sternotomy (LTHS) and CS. The primary outcome was severe RV failure. RESULTS: Eighty-three patients (LTHS: 37, CS: 46) were identified. The median Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) score was significantly worse in the LTHS compared to the CS cohort, and there was a trend towards higher RV failure scores and HeartMate II mortality scores. Preoperative RV dysfunction, in pulmonary artery pulsatility index and RV stroke work index were similar between the 2 groups. Though operative time did not significantly differ between the 2 groups, cardiopulmonary bypass time was significantly shorter in the LTHS group (61 vs 95 min, P < 0.001). The incidence of postoperative severe RV failure was significantly reduced in the LTHS group (16% vs 39%, P = 0.030), along with the need for temporary right ventricular assist device (3% vs 26%, P = 0.005). Improvement in RV function, along with a change in pulmonary artery pulsatility index, was significantly greater in the LTHS cohort. There was a trend towards improved Kaplan–Meier 1-year survival in the LTHS cohort (91% vs 56%, P = 0.056). CONCLUSIONS: In this cohort, less invasive LVAD implantation appears to be associated with reduced postoperative RV failure, and equivalent or improved survival compared to conventional LVAD implantation.

1 October 2023 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
MGMehrdad Ghoreishi
Mehrdad Ghoreishi
DCDiljon Chahal
Diljon Chahal
ASAakash Shah
Aakash Shah
JKJeanwan Kang
Jeanwan Kang
JHJeffrey Hirsch
Jeffrey Hirsch
STShahab Toursavadkohi
Shahab Toursavadkohi

18 May 2016 in Xenotransplantation
Verified
Journal Article
Open access
PDF file
LBLars Burdorf
Lars Burdorf
ARAndrea Nicole Riner
Andrea Nicole Riner
ERElana Rybak
Elana Rybak
Isabelle I Salles-CrawleyIsabelle I Salles-Crawley
Isabelle I Salles-Crawley
SMSimon F. De Meyer
Simon F. De Meyer
AAAgnes M. Azimzadeh
Agnes M. Azimzadeh
Background: Here, we ask whether platelet GPIb and GPIIb/IIIa receptors modulate platelet sequestration and activation during GalTKO.hCD46 pig lung xenograft perfusion.Methods: GalTKO.hCD46 transgenic pig lungs were perfused with heparinized fresh human blood. Results from perfusions in which αGPIb Fab (6B4, 10 mg/l blood, n = 6), αGPIIb/IIIa Fab (ReoPro, 3.5 mg/l blood, n = 6), or both drugs (n = 4) were administered to the perfusate were compared to two additional groups in which the donor pig received 1‐desamino‐8‐d‐arginine vasopressin (DDAVP), 3 μg/kg (to pre‐deplete von Willebrand Factor (pVWF), the main GPIb ligand), with or without αGPIb (n = 6 each).Results: Platelet sequestration was significantly delayed in αGPIb, αGPIb+DDAVP, and αGPIb+αGPIIb/IIIa groups. Median lung “survival” was significantly longer (>240 vs. 162 min reference, p = 0.016), and platelet activation (as CD62P and βTG) were significantly inhibited, when pigs were pre‐treated with DDAVP, with or without αGPIb Fab treatment. Pulmonary vascular resistance rise was not significantly attenuated in any group, and was associated with residual thromboxane and histamine elaboration.Conclusions: The GPIb‐VWF and GPIIb/IIIa axes play important roles in platelet sequestration and coagulation cascade activation during GalTKO.hCD46 lung xenograft injury. GPIb blockade significantly reduces platelet activation and delays platelet sequestration in this xenolung rejection model, an effect amplified by adding αGPIIb/IIIa blockade or depletion of VWF from pig lung.

1 January 2022 in Seminars in Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
NPNikhil K. Prasad
Nikhil K. Prasad
GBGregory Boyajian
Gregory Boyajian
DTDouglas Tran
Douglas Tran
ASAakash Shah
Aakash Shah
KJKevin M. Jones
Kevin M. Jones
DKDavid J Kaczorowski
David J Kaczorowski

11 June 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
CPCaroline M. Patterson
Caroline M. Patterson
ASAakash Shah
Aakash Shah
JRJoseph Rabin
Joseph Rabin
LDLaura DiChiacchio
Laura DiChiacchio
MCMarcelo Cypel
Marcelo Cypel
CLChristine L. Lau
Christine L. Lau